NON SMALL CELL LUNG CANCER METASTATIC
Clinical trials for NON SMALL CELL LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver zapping may supercharge lung cancer immunotherapy
Disease control Recruiting nowThis study tests whether adding a precise radiation dose to liver tumors can make standard immunotherapy work better for people with advanced non-small cell lung cancer (NSCLC) that has spread to the liver. About 68 participants will receive either standard drug therapy alone or …
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 17, 2026 02:16 UTC
-
New antibody drug targets Hard-to-Treat metastatic cancers
Disease control Recruiting nowThis study tests a new drug called OM-RCA-01 in people with several types of cancer that have spread to other parts of the body and have a specific marker (FGFR1). The drug is an antibody given through a vein every two weeks. The main goals are to find a safe dose and see if it c…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Kidney Cancer Research Bureau • Aim: Disease control
Last updated Jun 16, 2026 12:55 UTC
-
New combo tackles Drug-Resistant lung cancer in 47-Patient trial
Disease control Recruiting nowThis study tests whether combining two targeted drugs, lazertinib and tepotinib, can shrink tumors in people with a specific type of advanced lung cancer (EGFR-mutant NSCLC) that stopped responding to lazertinib alone. It includes 47 adults whose tumors show a change called MET o…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
Immune cells from your own tumor could fight lung cancer
Disease control Recruiting nowThis early-stage trial tests a treatment called GC101 TIL for people with advanced non-small cell lung cancer that has not responded to standard therapies. The treatment uses immune cells taken from the patient's own tumor, grown in a lab, and then given back to attack the cancer…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Protein test could tailor lung cancer therapy for better survival
Disease control Recruiting nowThis study tests whether using a protein-based test to guide treatment choices can help people with advanced non-small cell lung cancer live longer without their cancer getting worse. About 56 adults with stage IIIC or IV lung cancer will be randomly assigned to either standard t…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Could targeted radiation boost brain tumor control in lung cancer?
Disease control Recruiting nowThis study looks at whether adding a precise type of radiation (SRS) to a standard targeted therapy (osimertinib) is better than the drug alone for controlling brain metastases in people with a specific type of lung cancer (NSCLC with EGFR mutation). About 56 adults with at least…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC
-
Blood test could spare lung cancer patients from needless treatments
Disease control Recruiting nowThis study tests whether regular blood tests (liquid biopsies) can better monitor treatment in 350 people with advanced non-small cell lung cancer who are receiving immunotherapy. The goal is to see if this approach reduces the number of ineffective treatments and unnecessary sid…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: NA • Sponsor: Zealand University Hospital • Aim: Disease control
Last updated Jun 08, 2026 13:09 UTC
-
New hope for tough lung cancer: experimental drug takes on standard chemo
Disease control Recruiting nowThis study tests whether a new drug called PF-08046054 works better than the standard chemo docetaxel for people with advanced non-small cell lung cancer that has PD-L1 protein and has stopped responding to other treatments. About 680 adults will be randomly assigned to get one o…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 08, 2026 13:08 UTC
-
Blood test may personalize lung cancer therapy
Disease control Recruiting nowThis study tests whether a simple blood test (ctDNA) can help doctors decide if adding chemotherapy to the immunotherapy drug cemiplimab works better for advanced lung cancer. About 63 people with stage IV or stage IIIB/C non-small cell lung cancer that hasn't been treated before…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 03, 2026 12:04 UTC
-
Brain scans for silent spread: VULCAN trial tests routine MRI in advanced lung cancer
Knowledge-focused Recruiting nowThis study looks at whether a brain MRI is useful for people newly diagnosed with stage IV non-small cell lung cancer that has spread but does not yet cause brain symptoms. About 100 participants will get an MRI to check for hidden brain disease. The goal is to see if the scan ch…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: NA • Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC
-
Italian study tracks Real-Life results of triple therapy for lung cancer
Knowledge-focused Recruiting nowThis study is collecting information from 300 people in Italy with advanced non-small cell lung cancer who are receiving a combination of two immunotherapy drugs (nivolumab and ipilimumab) plus chemotherapy as their first treatment. The goal is to see how well this treatment work…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC
-
New study tracks how a targeted drug combo fights lung cancer in everyday care
Knowledge-focused Recruiting nowThis study watches 100 adults with metastatic non-small cell lung cancer who have certain EGFR gene changes and are already getting amivantamab plus chemotherapy through an early access program. Researchers want to see how long the cancer stays under control in real-world setting…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Sponsor: GFPC Investigation • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:09 UTC